530233 AUROLAB

Auro Laboratories Share Price

₹260.35 +23.65 (9.99%)

17 Jan, 2025 07:40

SIP TrendupStart SIP in AUROLAB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 7.18%
  • Over 3 Month + 8.77%
  • Over 6 Month + 47.09%
  • Over 1 Year + 110.38%
SIP Lightning

Smart Investing Starts Here Start SIP with Auro Laboratories for Steady Growth!

Invest Now

Auro Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Auro Laboratories Financials

Auro Laboratories Technicals

EMA & SMA

Current Price
₹260.35
+ 23.65 (9.99%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹249.16
  • 50 Day
  • ₹242.59
  • 100 Day
  • ₹229.60
  • 200 Day
  • ₹208.66

Resistance and Support

250.05 Pivot Speed
  • R3 300.45
  • R2 280.40
  • R1 270.10
  • S1 239.75
  • S2 219.70
  • S3 209.40

What's your outlook on Auro Laboratories?

You can only vote for once

Auro Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-09 Quarterly Results
2024-05-25 Audited Results
2024-02-06 Quarterly Results
2023-11-09 Quarterly Results

Auro Laboratories F&O

Auro Laboratories Shareholding Pattern

No data available.

About Auro Laboratories

  • NSE Symbol
  • AUROLAB
  • BSE Symbol
  • 530233
  • ISIN
  • INE292C01011

Similar Stocks to Auro Laboratories

Auro Laboratories FAQs

Auro Laboratories share price is ₹260 As on 17 January, 2025 | 07:26

The Market Cap of Auro Laboratories is ₹162.3 Cr As on 17 January, 2025 | 07:26

The P/E ratio of Auro Laboratories is 26.3 As on 17 January, 2025 | 07:26

The PB ratio of Auro Laboratories is 3.9 As on 17 January, 2025 | 07:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23